Skip to content

The enteral environment analysis using the human feces for the chronic liver disease and relative examination with the clinical data, multiple center study.

The enteral environment analysis using the human feces for the chronic liver disease and relative examination with the clinical data, multiple center study. - Chronic liver disease and enterobacteria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020917
Enrollment
500
Registered
2016-02-07
Start date
2016-02-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver disease (nonalcoholic steatohepatitis, nonalcoholic fatty liver disease), healthy volunteer

Interventions

None listed

Sponsors

Yokohama city university gastroenterology and hepatorogy
Lead Sponsor
Saga university JA hiroshima hospital Kawasaki medical university Kurume university
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who are diagnosed as follows: Chronic hepatitis patients, especially, NASH/NAFLD patients who are diagnosed based on the Medical treatment guide 2010 of NASH, NAFLD of Japanese liver society guidelines and healthy volunteer.

Exclusion criteria

Exclusion criteria: 1) Re-registration example to the examination 2) The patients with malignant tumor 3) In addition, the patient who judged an arrangement to the examination if the medical attendant was inappropriate 4) The patients that specimen collection is not possible by dyschezia.

Design outcomes

Primary

MeasureTime frame
Difference of bacterial flora between healthy volunteer and each chronic liver disease.

Secondary

MeasureTime frame
Difference of parameters as below between healthy volunteer and each chronic liver disease. Blood: endotoxin, metabolome(bile acid, organic acid, short chain fatty acid, amino acid etc.). Feces: metabolome (bile acid, organic acid, short chain fatty acid, amino acid etc.), mucin Urine: lactulose mannnitol ratio. Comparison of the above items with clinical findings.

Countries

Japan

Contacts

Public ContactKento Imajo

Yokohama city university Gastroentelorogy and hepatology

kento318@yokohama-cu.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026